# Novalent Biotech, Inc. — Form D

Novalent Biotech, Inc. of GREENSBORO, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-29. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-11-29
- Form: D
- Accession: 0001895518-21-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $11.0M
- Amount sold: $11.0M
- Minimum investment: $10K
- Investors: 712
- Date of first sale: 2021-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-422700

## Issuer

- Name: Novalent Biotech, Inc.
- CIK: 0001895518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2319 JOE BROWN DR., GREENSBORO, NC, 27405
- Phone: 3363757555

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Bill Massa | Director | Greensboro, NC |
| Alex Ovchar | Director | Greensboro, NC |
| Kevin Parrish | Director | Greensboro, NC |
| Bill Massa | Executive Officer | Greensboro, NC |
| Alex Ovchar | Executive Officer | Greensboro, NC |
| Kevin Parrish | Executive Officer | Greensboro, NC |
| Wayne Thompson | Executive Officer | Greensboro, NC |

## More

- [CIK 1895518 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1895518&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001895518-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.